ANDA 76988, held by Nesher Pharmaceuticals. Prednisolone Sodium Phosphate.
As of Nov 21, 2026, ANDA 76988 (Prednisolone Sodium Phosphate), held by Nesher Pharmaceuticals, was first approved by FDA on May 24, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 24, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 15MG BASE/5ML · solution;oral | Prednisolone Sodium Phosphate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters